18.39
Schlusskurs vom Vortag:
$18.10
Offen:
$18.1
24-Stunden-Volumen:
2.05M
Relative Volume:
0.98
Marktkapitalisierung:
$5.25B
Einnahmen:
$1.19B
Nettoeinkommen (Verlust:
$117.80M
KGV:
44.82
EPS:
0.4103
Netto-Cashflow:
$92.48M
1W Leistung:
+2.57%
1M Leistung:
+0.27%
6M Leistung:
+16.32%
1J Leistung:
+10.05%
Sotera Health Co Stock (SHC) Company Profile
Firmenname
Sotera Health Co
Sektor
Branche
Telefon
440-262-1410
Adresse
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SHC
Sotera Health Co
|
18.39 | 5.25B | 1.19B | 117.80M | 92.48M | 0.4103 |
|
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
|
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2026-06-05 | Eingeleitet | Goldman | Buy |
| 2026-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-12-18 | Eingeleitet | William Blair | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-05-05 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-06 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Eingeleitet | Piper Sandler | Neutral |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-03-25 | Hochstufung | Jefferies | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-01-11 | Hochstufung | Barclays | Underweight → Overweight |
| 2023-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-09-20 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Sotera Health Co Aktie (SHC) Neueste Nachrichten
An investment adviser and three related parties report no shares in Sotera Health (SHC). - Stock Titan
Sotera Health (SHC) Looks Cheaper As Short Term Momentum Cools - Simply Wall Street
Sotera Health Company (SHC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Here’s Why Sotera Health Company (SHC) Surges 25% in Q2 - Yahoo Finance
3 of Wall Street’s Favorite Stocks We Approach with Caution - Yahoo Finance
3 of Wall Street’s Favorite Stocks We Approach with Caution - StockStory
Sotera Health at Wells Fargo healthcare conference: growth and cash flow - investing.com
Sotera Health at Wells Fargo healthcare conference: growth and cash flow - Investing.com Canada
Sotera Health at Wells Fargo healthcare conference: growth and cash flow - Investing.com India
Piper Sandler reiterates Sotera Health stock rating on growth outlook By Investing.com - Investing.com South Africa
Piper Sandler reiterates Sotera Health stock rating on growth outlook - Investing.com
Sotera Health Co (SHC) Peer Comparison – Compare with Others - Value Research
Insider Selling: Michael Petras Jr Unloads $21.17M Of Sotera Health Stock - Benzinga
Bank of America Corp DE Buys 991,620 Shares of Sotera Health Company $SHC - MarketBeat
Insider Selling: Sotera Health (NASDAQ:SHC) Chairman Sells 850,000 Shares - MarketBeat
Research Tools & Consumables Stocks Q2 Recap: Benchmarking Sotera Health Company (NASDAQ:SHC) - Yahoo Finance
Sotera Health (NASDAQ: SHC) affiliate eyes $21.6M stock sale - Stock Titan
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
State of Wyoming Buys Shares of 56,651 Sotera Health Company $SHC - MarketBeat
Sotera Health president Rutz sells $2.83m in common stock - Investing.com
Sotera Health president Rutz sells $2.83m in common stock - Investing.com
What Sotera Health (SHC)'s Strong Q2 Beat and Raised Outlook Means For Shareholders - simplywall.st
Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Sotera Health president Rutz sells $2.83m in common stock By Investing.com - Investing.com Nigeria
Sotera Health (SHC): Sculptor Capital discloses 24M-share, 8.41% ownership stake - Stock Titan
Sotera Health (SHC): Sessa Capital discloses 27M-share, 9.5% ownership position - Stock Titan
Sotera Health announces resignation of director James C. Neary - Investing.com
Sotera Health announces resignation of director James C. Neary By Investing.com - Investing.com Nigeria
Form 8K Sotera Health Co For: 14 August By Investing.com - Investing.com Nigeria
Sotera Health announces resignation of director James C. Neary By Investing.com - Investing.com Australia
Sotera Health announces resignation of director James C. Neary By Investing.com - Investing.com India
Form 8K Sotera Health Co For: 14 August By Investing.com - Investing.com Canada
Form 8K Sotera Health Co For: 14 August By Investing.com - Investing.com India
Form 8K Sotera Health Co For: 14 August By Investing.com - Investing.com UK
James C. Neary Steps Down from Sotera Health Board, Board Size Now Eleven - Kalkine Media
Loving Living Local: Solvera Health - AOL.com
President of Sterigenics U.S. Of Sotera Health Sold 37% Of Their Shares - simplywall.st
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings? - StockStory
Sotera Health Company (SHC) Stock Forecasts - Yahoo Finance
Insider Transaction: Michael Rutz Sells $2.83M Worth Of Sotera Health Shares - Benzinga
Sotera Health Company (SHC) Stock forecasts - Yahoo Finance UK
Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock - MarketBeat
Quantinno Capital Management LP Has $2.83 Million Position in Sotera Health Company $SHC - MarketBeat
Sotera Health (SHC) Is Getting Attention Again, What Is Behind It? - simplywall.st
Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins - Yahoo Finance
Renaissance Technologies LLC Reduces Holdings in Sotera Health Company $SHC - MarketBeat
SHC Q2 Deep Dive: Broad-Based Growth, Leadership Transition, and Strategic Investments Shape Outlook - Yahoo Finance
Sotera Health (SHC) Stock Trails Profit Surge As Legal Risks Linger - simplywall.st
SHC SWOT Analysis: Strong Revenue Growth Amidst Legal Challenges Revealed in 10-Q Filing - GuruFocus
Finanzdaten der Sotera Health Co-Aktie (SHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sotera Health Co-Aktie (SHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Petras Michael B. Jr. | Executive Chairman |
Aug 17 '26 |
Sale |
18.50 |
294,515 |
5,448,851 |
397,912 |
| Michael B. Petras, Jr. | Chairman, CEO |
Aug 17 '26 |
Proposed Sale |
18.89 |
1,144,515 |
21,619,888 |
0 |
| Rutz Michael P | President of Sterigenics |
Aug 07 '26 |
Sale |
18.84 |
150,000 |
2,825,250 |
334,279 |
| Rutz Michael P | Officer |
Aug 07 '26 |
Proposed Sale |
18.91 |
150,000 |
2,836,500 |
0 |
| WARBURG PINCUS & CO. | Director |
May 13 '26 |
Sale |
15.17 |
19,102,952 |
289,753,576 |
0 |
| WARBURG PINCUS & CO. | Director |
May 13 '26 |
Sale |
15.17 |
19,102,952 |
289,753,576 |
0 |
| GTCR INVESTMENT XI LLC | Director |
May 13 '26 |
Sale |
15.17 |
12,735,301 |
193,169,046 |
0 |
| WARBURG PINCUS & CO. | Director |
Mar 06 '26 |
Sale |
15.27 |
15,000,000 |
229,050,000 |
19,102,952 |
| WARBURG PINCUS & CO. | Director |
Mar 06 '26 |
Sale |
15.27 |
15,000,000 |
229,050,000 |
19,102,952 |
| GTCR INVESTMENT XI LLC | Director |
Mar 06 '26 |
Sale |
15.27 |
10,000,000 |
152,700,000 |
12,735,301 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):